Substituted piperidine compounds and methods of their use

Details Substituted piperidine compounds and methods of their use Substituted piperidine compounds and methods of their use

2006-08-08

2006-08-08

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C546S112000

Reexamination Certificate

active

07087749

ABSTRACT:
Certain 4-aryl-piperidine compounds, including N-substituted 9β-substituted-5-(3-substituted-phenyl)morphans and N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines, pharmaceutical compositions, and methods of their use, inter alia, as opioid antagonists are disclosed.

REFERENCES:
patent: 4176186 (1979-11-01), Goldberg et al.
patent: 4987126 (1991-01-01), Bargiotti et al.
patent: 5159081 (1992-10-01), Cantrell et al.
patent: 5250542 (1993-10-01), Cantrell et al.
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5434171 (1995-07-01), Frank et al.
patent: 5731322 (1998-03-01), Dondio et al.
patent: 5972954 (1999-10-01), Foss et al.
patent: 6531481 (2003-03-01), Carroll et al.
patent: WO 99/45925 (1999-09-01), None
Thomas, J. Med. Chem. vol. 41, pp. 4143-4149, 1998.
Thomas, Tetrahedron Letters, vol. 40, pp. 403-406, 1999.
Jacobson, Chemical Abstracts abstract 125:185591, 1995.
Aceto, Chemical Abstracts abstract 125:185593, 1996.
Bagnol, D., et al., “Changes in enkephalin immunoreactivity of sympathetic ganglia and digestive tract of the cat after splanchnic nerve ligation,”Regul. Peptides, 1993, 47, 259-273.
Bagnol, D., et al., “Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract,”Neuroscience, 1997, 81(2), 579-591.
Bhargava, H.N., et al., “Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of D-Pen2, D-Pen5enkephalin and morphine in the mouse,”Neuropeptides, 1996, 30(3), 219-223.
Bilsky, E.J., “Effects of naloxone and D-phe-cys-tyr-D-trp-arg-thr-pen-thr-NH2and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice,”J. Pharmacol. Exp. Ther., 1996, 277, 484-490.
Buschmann, H., et al., Verlag GMbH & Co. KgaA, Weinheim, 2002.
Dorland's Illustrated Medical Dictionary, 27thEd.,W.B. Saunders Co., Phila., PA, 1988, p. 816.
Dorland's Illustrated Medical Dictionary, 27thEd.,W.B. Saunders Co., Phila., PA, 1988, p. 375.
Dourish, C.T., et al., “Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364, 718,”Eur. J. Pharmacol., 1988, 147, 469-472.
Drewes, S.E., et al., “Synthesis, resolution and assignment of absolute configuration of 2-(α-hydroxy)aryl acrylate esters,”Tetrah.: Asymmetry, 1992, 3(2), 255-260.
Greene, T.W., et al., Protective Groups in Organic Synthesis, 3rdEd.,Wiley&Sons, 1991.
Jain, K.K., “A guide to drug evaluation for chronic pain,”Emerging Drugs, 2000, 5(2), 241-257.
Koch, T.R., et al., “Inhibitory neuropeptides and intrinsic inhibitory innervation of descending human colon,”Digestive Diseases&Sciences, 1991, 36(6), 712-718.
Kreek, M.-J., et al., “Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation,”J. Lancet, 1983, 261-262.
Livingston, E.H., et al., “Postoperative ileus,”Digestive Diseases and Sciences, 1990, 35(1), 121-132.
Mack, D.J., “Paralytic ileus: response to naloxone,”Br. J. Surg., 1989, 76(10), p. 1101.
Mao, M.J., et al., “Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats,”Pain, 1996, 67, 361-368.
Nichols, M.L., et al., “Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy,”Pain, 1997, 69, 317-322.
Perlmutter, P., et al., “A simple route to α-substituted-β-amino ester precursors of carbapenem antibiotics,”J. Org. Chem., 1995, 60, 6515-6522.
Perlmutter, P., et al., “Diastereoselection in the nucleophilic conjugate addition of amines to 2-hydroxyalkylpropenoates,”Tetrah. Lettl., 1988, 29(8), 949-952.
Physician's Desk Reference, 1999.
Reisine, T., et al., “Opioid analgesics and antagonists,”Goodman&Gilman's The Pharmacological Basis of Therapeutics, 9thEd., 1996, Chapter 23, 521-555.
Remington's Pharmaceutical Sciences,Mack Pub. Co., Easton, PA, 1980.
Resnick, J., et al., “Delayed gastric emptying and postoperative Ileus after nongastric abdominal surgery: Part I,”Am. J. of Gastroenterology, 1997, 92(5), 751-762.
Resnick, J., et al., “Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: Part II,”Am. J. of Gastroenterology, 1997, 92(6), 934-940.
Schang, J.C., et al., “Beneficial effects of naloxone in a patient with intestinal pseudoobstruction,”Am. J. Gastroenerol, 1985, 80(6), 407-411.
Schuller, A.G.P., et al., “M6G, but not morphine, inhibits GI transit in MU opioid receptor deficient mice,” Abstract No. 210.7,Society of Neurosc., 1998, 24, p. 524.
Shaw, W.N., et al., “Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese zucker rat,”J. Pharm.&Exp. Ther., 1990, 253(1), 85-89.
Thomas, J.B., et al., “N-substituted 9β-methyl-5-(-3hydroxyphenyl)morphans are opioid receptor pure antagonists,”J. Med. Chem., 1998, 41, 4143-4149.
Werner, J.A., et al., “Synthesis oftrans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists: application of theCis-thermal elimination of carbonates to alkaloid synthesis,”J. Org. Chem., 1996, 61(2), 587-597.
Wittert, G., et al., “Tissue distribution of opioid receptor gene expression in the rat,”Biochem&Biophys. Res. Commun., 1996, 218(3), 877-881.
Zimmerman, D.J., et al., “Discovery of a potent, peripherally selectivetrans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine opioid antagonist for the treatment of gastrointestinal motility disorders,”J. Med. Chem., 1994, 37(15), 2262-2265.
Thomas, J.B., et al., “N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists,”Bioorganic&Medicinal Chem. Letts., 1998, 8, 3149-3152.

Affiliated with

Also associated with

Rating

Substituted piperidine compounds and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted piperidine compounds and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidine compounds and methods of their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3708646